Raj K. Keservani, MPharm, is a Faculty of B. Pharmacy, CSM Group of Institutions, Allahabad, India. He has more than 12 years of academic (teaching) experience from various institutes of India in pharmaceutical education. He has published 31 peer-reviewed papers in the field of pharmaceutical sciences in national and international journals, 43 book chapters, three co-authored books, and 18 edited books. He is also active as a reviewer for several international scientific journals. Mr. Keservani graduated with a pharmacy degree from the Department of Pharmacy, Kumaun University, Nainital (Uttarakhand), India. He received his Master of Pharmacy (MPharm) (specialization in pharmaceutics) from the School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, India. Mr. Keservani is a life member of Society of Pharmaceutical Education and Research (SPER). His research interests include nutraceutical and functional foods, novel drug delivery systems (NDDS), transdermal drug delivery/drug delivery, health science, cancer biology, and neurobiology.
Rajesh K. Kesharwani, PhD, MTech, has more than 10 years of research and eight years of teaching experience at various institutes of India, imparting bioinformatics, and biotechnology education. He has received several awards, including the NASI-Swarna Jayanti Puruskar by The National Academy of Sciences of India. He has supervised PhD, postgraduate, and undergraduate students for their research work and has authored over 40 peer-reviewed articles, 20 book chapters, and 11 edited books with international publishers. Dr. Kesharwani received his PhD from the Indian Institute of Information Technology, Allahabad, India, and worked at NIT Warangal. He has been a recipient of the Ministry of Human Resource Development (India) Fellowship and Senior Research Fellowship from the Indian Council of Medical Research, India. His research fields of interest are medical informatics, protein structure and function prediction, computer-aided drug designing, structural biology, drug delivery, cancer biology, nano-biotechnology, and biomedical sciences.
Prof. Mila Emerald, Ph.D., Dr. Sc., President and CEO at PHYTOCEUTICALS International (TM) & NOVOTEK Global Solutions (TM), Ph.D. in Cellular Biochemistry and Molecular Biophysics, Dr. Science in Neuroscience, and professorship from the Cornell University, dedicated her life to research of nutraceuticals and natural products, their therapeutic properties, and applications. Her work, business, and research are dedicated to the role of natural nanomaterials and novel drugs delivery systems, in nutraceuticals, fermented products, functional foods, probiotics, essential oils and natural extracts complexes, and their crucial role in human wellbeing and health. She is also focused on the natural compounds, which can potentially be used in prevention and maintenance of bacterial, fungal, as well as viral pathogens, including SARS-COV2. Dr. M. Emerald is honoured to be one of the winners in the International Challenge called: Next Great Impossible on Nanotechnology, by Sigma-Aldrich/Merck, one of the most viewed profiles on the LinkedIn.
Anil K. Sharma, PhD, MPharm, is working as an assistant professor at the Department of Pharmacy, School of Medical and Allied Sciences, GD Goenka University, Gurugram, India. He has more than ten years of academic experience in pharmaceutical sciences. He has published 35 peer-reviewed papers in the field of pharmaceutical sciences in national and international journals as well as 28 book chapters. In addition, he has edited 16 books with reputable publishers. He received a bachelor´s degree in pharmacy from the University of Rajasthan, Jaipur, India, and a Master of Pharmacy degree from the School of Pharmaceutical Sciences, Rajiv Gandhi ProudyogikiVishwavidyalaya, Bhopal, India, with a specialization in pharmaceutics. He earned his PhD in pharmacy from the University of Delhi, India.His research interests encompass nutraceutical and functional foods, novel drug delivery systems (NDDS), drug delivery, nanotechnology, health science/life science, and biology/cancer biology/neurobiology.
